WAZ, Dorota et al. Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice. Quality in Sport, [S. l.], v. 38, p. 57232, 2025. DOI: 10.12775/QS.2025.38.57232. Disponível em: https://apcz.umk.pl/QS/article/view/57232. Acesso em: 28 jun. 2025.